Industry: Pharma & Healthcare
Published Date: 2026-04-28
Pages: 130 Pages
Report ld: 5778839
Request Sample
Customized Report
Parenteral Excipients Market Size(US$)

CAGR 2026-2032
5.3%
Market Size,2032
USD 1,534
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Parenteral Excipients was estimated to be worth US$ 1067 million in 2025 and is projected to reach US$ 1534 million, growing at a CAGR of 5.3% from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Parenteral Excipients cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Parenteral excipients for injection are inactive ingredients used in injections, infusions, and lyophilized formulations. They primarily function to solubilize, stabilize, buffer, adjust tonicity, provide antioxidant protection, and protect the active ingredient, while meeting requirements for high purity, low endotoxin levels, and good injection safety.
Upstream suppliers mainly include pharmaceutical-grade sugars, amino acids, surfactants, buffer salts, chelating agents, antioxidants, solvents, aseptic packaging materials, and high-purity raw material suppliers. Downstream applications primarily target chemical injections, biopharmaceuticals, vaccines, liposomes, long-acting formulations, lyophilized powder injections, and CDMOs.
The global market price for parenteral excipients for injection is $7,511 per ton, with annual sales of approximately 142,000 tons and a global annual production capacity of approximately 180,000-200,000 tons. The industry profit margin is 15%.
The future global market for parenteral excipients for injection will move towards higher purity, higher functionality, and regulatory-driven upgrades. With the continued expansion of biologics, vaccines, complex injectable formulations, and high-concentration formulations, the market demand for excipients that solubilize, stabilize proteins/nucleic acids, control particulate matter and impurities, and improve compatibility and long-term storage performance will significantly increase. Simultaneously, regulatory agencies and pharmacopoeias are imposing stricter requirements on the quality attributes, impurity profiles, aseptic assurance, and specific application standards of injectable excipients, driving the supply chain towards greater consistency and traceability. On the other hand, multifunctional excipients, pre-formulated systems, and specialized excipients better suited for lipid nanoparticles, sustained-release injections, and biologics will become important directions.
This report provides a comprehensive view of the global market for Parenteral Excipients, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Parenteral Excipients market size, estimations, and forecasts are presented in terms of sales volume (K Tons) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Parenteral Excipients.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Parenteral Excipients manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Parenteral Excipients sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Parenteral Excipients sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Parenteral Excipients Product Introduction
1.2 Global Parenteral Excipients Market Size Forecast
1.2.1 Global Parenteral Excipients Sales Value (2021–2032)
1.2.2 Global Parenteral Excipients Sales Volume (2021–2032)
1.2.3 Global Parenteral Excipients Sales Price (2021–2032)
1.3 Parenteral Excipients Market Trends & Drivers
1.3.1 Parenteral Excipients Industry Trends
1.3.2 Parenteral Excipients Market Drivers & Opportunities
1.3.3 Parenteral Excipients Market Challenges
1.3.4 Parenteral Excipients Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Parenteral Excipients Players Revenue Ranking (2025)
2.2 Global Parenteral Excipients Revenue by Company (2021–2026)
2.3 Global Parenteral Excipients Sales Volume Ranking of Players (2025)
2.4 Global Parenteral Excipients Sales Volume by Company (2021–2026)
2.5 Global Parenteral Excipients Average Price by Company (2021–2026)
2.6 Key Manufacturers Parenteral Excipients Manufacturing Base and Headquarters
2.7 Key Manufacturers Parenteral Excipients Product Offerings
2.8 Key Manufacturers Start of Mass Production of Parenteral Excipients
2.9 Parenteral Excipients Market Competitive Analysis
2.9.1 Parenteral Excipients Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Parenteral Excipients Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Parenteral Excipients revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Parenteral Excipients Market Classification
3.1 Introduction by Type
3.1.1 Solubilizers
3.1.2 Bulker
3.1.3 Preservatives
3.1.4 Solvents
3.1.5 Others
3.1.6 Global Parenteral Excipients Sales Value by Type
3.1.6.1 Global Parenteral Excipients Sales Value by Type (2021 vs 2025 vs 2032)
3.1.6.2 Global Parenteral Excipients Sales Value, by Type (2021–2032)
3.1.6.3 Global Parenteral Excipients Sales Value, by Type (%), 2021–2032
3.1.7 Global Parenteral Excipients Sales Volume by Type
3.1.7.1 Global Parenteral Excipients Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.7.2 Global Parenteral Excipients Sales Volume, by Type (2021–2032)
3.1.7.3 Global Parenteral Excipients Sales Volume, by Type (%), 2021–2032
3.1.8 Global Parenteral Excipients Average Price by Type (2021–2032)
3.2 Introduction by Source
3.2.1 Natural Source Excipients
3.2.2 Semi-Synthetic Excipients
3.2.3 Synthetic Excipients
3.2.4 Bio-Derived Excipients
3.2.5 Global Parenteral Excipients Sales Value by Source
3.2.5.1 Global Parenteral Excipients Sales Value by Source (2021 vs 2025 vs 2032)
3.2.5.2 Global Parenteral Excipients Sales Value, by Source (2021–2032)
3.2.5.3 Global Parenteral Excipients Sales Value, by Source (%), 2021–2032
3.2.6 Global Parenteral Excipients Sales Volume by Source
3.2.6.1 Global Parenteral Excipients Sales Volume by Source (2021 vs 2025 vs 2032)
3.2.6.2 Global Parenteral Excipients Sales Volume, by Source (2021–2032)
3.2.6.3 Global Parenteral Excipients Sales Volume, by Source (%), 2021–2032
3.2.7 Global Parenteral Excipients Average Price by Source (2021–2032)
3.3 Introduction by Dosage Form
3.3.1 Excipients for Injection
3.3.2 Excipients for Infusion
3.3.3 Excipients for Lyophilized Powder for Injection
3.3.4 Excipients for Emulsions/Suspensions
3.3.5 Excipients For Liposomes/Lnps
3.3.6 Others
3.3.7 Global Parenteral Excipients Sales Value by Dosage Form
3.3.7.1 Global Parenteral Excipients Sales Value by Dosage Form (2021 vs 2025 vs 2032)
3.3.7.2 Global Parenteral Excipients Sales Value, by Dosage Form (2021–2032)
3.3.7.3 Global Parenteral Excipients Sales Value, by Dosage Form (%), 2021–2032
3.3.8 Global Parenteral Excipients Sales Volume by Dosage Form
3.3.8.1 Global Parenteral Excipients Sales Volume by Dosage Form (2021 vs 2025 vs 2032)
3.3.8.2 Global Parenteral Excipients Sales Volume, by Dosage Form (2021–2032)
3.3.8.3 Global Parenteral Excipients Sales Volume, by Dosage Form (%), 2021–2032
3.3.9 Global Parenteral Excipients Average Price by Dosage Form (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Precision Medicine
4.1.2 Biopharmaceuticals
4.1.3 Others
4.2 Global Parenteral Excipients Sales Value by Application
4.2.1 Global Parenteral Excipients Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Parenteral Excipients Sales Value, by Application (2021–2032)
4.2.3 Global Parenteral Excipients Sales Value, by Application (%), 2021–2032
4.3 Global Parenteral Excipients Sales Volume by Application
4.3.1 Global Parenteral Excipients Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Parenteral Excipients Sales Volume, by Application (2021–2032)
4.3.3 Global Parenteral Excipients Sales Volume, by Application (%), 2021–2032
4.4 Global Parenteral Excipients Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Parenteral Excipients Sales Value by Region
5.1.1 Global Parenteral Excipients Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Parenteral Excipients Sales Value by Region (2021–2026)
5.1.3 Global Parenteral Excipients Sales Value by Region (2027–2032)
5.1.4 Global Parenteral Excipients Sales Value by Region (%), 2021–2032
5.2 Global Parenteral Excipients Sales Volume by Region
5.2.1 Global Parenteral Excipients Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Parenteral Excipients Sales Volume by Region (2021–2026)
5.2.3 Global Parenteral Excipients Sales Volume by Region (2027–2032)
5.2.4 Global Parenteral Excipients Sales Volume by Region (%), 2021–2032
5.3 Global Parenteral Excipients Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Parenteral Excipients Sales Value, 2021–2032
5.4.2 North America Parenteral Excipients Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Parenteral Excipients Sales Value, 2021–2032
5.5.2 Europe Parenteral Excipients Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Parenteral Excipients Sales Value, 2021–2032
5.6.2 Asia Pacific Parenteral Excipients Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Parenteral Excipients Sales Value, 2021–2032
5.7.2 South America Parenteral Excipients Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Parenteral Excipients Sales Value, 2021–2032
5.8.2 Middle East & Africa Parenteral Excipients Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Parenteral Excipients Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Parenteral Excipients Sales Value and Sales Volume
6.2.1 Key Countries/Regions Parenteral Excipients Sales Value, 2021–2032
6.2.2 Key Countries/Regions Parenteral Excipients Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Parenteral Excipients Sales Value, 2021–2032
6.3.2 United States Parenteral Excipients Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Parenteral Excipients Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Parenteral Excipients Sales Value, 2021–2032
6.4.2 Europe Parenteral Excipients Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Parenteral Excipients Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Parenteral Excipients Sales Value, 2021–2032
6.5.2 China Parenteral Excipients Sales Value by Type (%), 2025 vs 2032
6.5.3 China Parenteral Excipients Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Parenteral Excipients Sales Value, 2021–2032
6.6.2 Japan Parenteral Excipients Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Parenteral Excipients Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Parenteral Excipients Sales Value, 2021–2032
6.7.2 South Korea Parenteral Excipients Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Parenteral Excipients Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Parenteral Excipients Sales Value, 2021–2032
6.8.2 Southeast Asia Parenteral Excipients Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Parenteral Excipients Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Parenteral Excipients Sales Value, 2021–2032
6.9.2 India Parenteral Excipients Sales Value by Type (%), 2025 vs 2032
6.9.3 India Parenteral Excipients Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Merck
7.1.1 Merck Company Information
7.1.2 Merck Introduction and Business Overview
7.1.3 Merck Parenteral Excipients Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Merck Parenteral Excipients Product Offerings
7.1.5 Merck Recent Developments
7.2 Ashland
7.2.1 Ashland Company Information
7.2.2 Ashland Introduction and Business Overview
7.2.3 Ashland Parenteral Excipients Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Ashland Parenteral Excipients Product Offerings
7.2.5 Ashland Recent Developments
7.3 Roquette
7.3.1 Roquette Company Information
7.3.2 Roquette Introduction and Business Overview
7.3.3 Roquette Parenteral Excipients Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Roquette Parenteral Excipients Product Offerings
7.3.5 Roquette Recent Developments
7.4 Croda Pharma
7.4.1 Croda Pharma Company Information
7.4.2 Croda Pharma Introduction and Business Overview
7.4.3 Croda Pharma Parenteral Excipients Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Croda Pharma Parenteral Excipients Product Offerings
7.4.5 Croda Pharma Recent Developments
7.5 BASF
7.5.1 BASF Company Information
7.5.2 BASF Introduction and Business Overview
7.5.3 BASF Parenteral Excipients Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 BASF Parenteral Excipients Product Offerings
7.5.5 BASF Recent Developments
7.6 Evonik
7.6.1 Evonik Company Information
7.6.2 Evonik Introduction and Business Overview
7.6.3 Evonik Parenteral Excipients Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Evonik Parenteral Excipients Product Offerings
7.6.5 Evonik Recent Developments
7.7 Seppic
7.7.1 Seppic Company Information
7.7.2 Seppic Introduction and Business Overview
7.7.3 Seppic Parenteral Excipients Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Seppic Parenteral Excipients Product Offerings
7.7.5 Seppic Recent Developments
7.8 Lubrizol
7.8.1 Lubrizol Company Information
7.8.2 Lubrizol Introduction and Business Overview
7.8.3 Lubrizol Parenteral Excipients Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Lubrizol Parenteral Excipients Product Offerings
7.8.5 Lubrizol Recent Developments
7.9 Pfanstiehl
7.9.1 Pfanstiehl Company Information
7.9.2 Pfanstiehl Introduction and Business Overview
7.9.3 Pfanstiehl Parenteral Excipients Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 Pfanstiehl Parenteral Excipients Product Offerings
7.9.5 Pfanstiehl Recent Developments
8 Industry Chain Analysis
8.1 Parenteral Excipients Industrial Chain
8.2 Parenteral Excipients Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Parenteral Excipients Sales Model
8.5.2 Sales Channels
8.5.3 Parenteral Excipients Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Parenteral Excipients market is projected to grow from US$ 1067 million in 2025 to US$ 1534 million by 2032, at a CAGR of 5.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-04-28
Pages: 138
USD 4900.00
(Single User License)
The global Parenteral Excipients market size was US$ 1067 million in 2025 and is forecast to reach a readjusted size of US$ 1534 million by 2032 with a CAGR of 5.3% during the forecast period 2026-2032.
Published Date: 2026-04-28
Pages: 135
USD 4250.00
(Single User License)
The global Parenteral Excipients market was valued at US$ 1067 million in 2025 and is anticipated to reach US$ 1534 million by 2032, at a CAGR of 5.3% from 2026 to 2032.
Published Date: 2026-04-28
Pages: 108
USD 2900.00
(Single User License)
The global Parenteral Excipients market is projected to grow from US$ 1588 million in 2024 to US$ 2283 million by 2031, at a CAGR of 5.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 136
USD 4900.00
(Single User License)
The global market for Parenteral Excipients was estimated to be worth US$ 1588 million in 2024 and is forecast to a readjusted size of US$ 2283 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Published Date: 2025-03-13
Pages: 108
USD 3950.00
(Single User License)
The global Parenteral Excipients market size was US$ 1588 million in 2024 and is forecast to a readjusted size of US$ 2283 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Published Date: 2025-03-13
Pages: 78
USD 4250.00
(Single User License)
The global market for Parenteral Excipients was valued at US$ 1588 million in the year 2024 and is projected to reach a revised size of US$ 2283 million by 2031, growing at a CAGR of 5.4% during the forecast period.
Published Date: 2025-03-13
Pages: 83
USD 2900.00
(Single User License)
The global market for Parenteral Excipients was estimated to be worth US$ 1588 million in 2024 and is forecast to a readjusted size of US$ 2283 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 92
USD 3950.00
(Single User License)
The global market for Parenteral Excipients was estimated to be worth US$ 1547 million in 2023 and is forecast to a readjusted size of US$ 2177 million by 2030 with a CAGR of 5.4% during the forecast period 2024-2030.
Published Date: 2025-01-04
Pages: 101
USD 3950.00
(Single User License)
The global market for Parenteral Excipients was valued at US$ 1547 million in the year 2023 and is projected to reach a revised size of US$ 2177 million by 2030, growing at a CAGR of 5.4% during the forecast period.
Published Date: 2025-01-04
Pages: 86
USD 2900.00
(Single User License)
The global Parenteral Excipients market is projected to grow from US$ 1067 million in 2025 to US$ 1534 million by 2032, at a CAGR of 5.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-04-28
Pages: 138
The global Parenteral Excipients market size was US$ 1067 million in 2025 and is forecast to reach a readjusted size of US$ 1534 million by 2032 with a CAGR of 5.3% during the forecast period 2026-2032.
Published: 2026-04-28
Pages: 135
The global Parenteral Excipients market was valued at US$ 1067 million in 2025 and is anticipated to reach US$ 1534 million by 2032, at a CAGR of 5.3% from 2026 to 2032.
Published: 2026-04-28
Pages: 108
The global Parenteral Excipients market is projected to grow from US$ 1588 million in 2024 to US$ 2283 million by 2031, at a CAGR of 5.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 136
The global market for Parenteral Excipients was estimated to be worth US$ 1588 million in 2024 and is forecast to a readjusted size of US$ 2283 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Published: 2025-03-13
Pages: 108
The global Parenteral Excipients market size was US$ 1588 million in 2024 and is forecast to a readjusted size of US$ 2283 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Published: 2025-03-13
Pages: 78
The global market for Parenteral Excipients was valued at US$ 1588 million in the year 2024 and is projected to reach a revised size of US$ 2283 million by 2031, growing at a CAGR of 5.4% during the forecast period.
Published: 2025-03-13
Pages: 83
The global market for Parenteral Excipients was estimated to be worth US$ 1588 million in 2024 and is forecast to a readjusted size of US$ 2283 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 92
The global market for Parenteral Excipients was estimated to be worth US$ 1547 million in 2023 and is forecast to a readjusted size of US$ 2177 million by 2030 with a CAGR of 5.4% during the forecast period 2024-2030.
Published: 2025-01-04
Pages: 101
The global market for Parenteral Excipients was valued at US$ 1547 million in the year 2023 and is projected to reach a revised size of US$ 2177 million by 2030, growing at a CAGR of 5.4% during the forecast period.
Published: 2025-01-04
Pages: 86
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now